Whole-body diffusion-weighted imaging for staging malignant lymphoma in children

Pediatric Radiology

Volumn 40, Issue 10, 2010, Pages 1592-1602

  Kwee, Thomas C ^a   Takahara, Taro ^a   Vermoolen, Malou A ^a   Bierings, Marc B ^a   Mali, Willem P ^a   Nievelstein, Rutger A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Children; Diffusion weighted imaging; Malignant lymphoma; MRI; Whole body MRI

Indexed keywords

ADOLESCENT; CANCER STAGING; CASE REPORT; CHILD; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LYMPHOMA; MALE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TECHNIQUE; WHOLE BODY IMAGING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; INFANT; LYMPHOMA; NEOPLASM STAGING; WHOLE BODY IMAGING;

EID: 77957593142     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-010-1775-7     Document Type: Review

References (69)

1. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. E Steliarova-Foucher C Stiller P Kaatsch, et al. 2004 Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study Lancet 364 2097 2105 10.1016/S0140-6736(04)17550-8 15589307 (Pubitemid 39626805)
3. JM Connors 2005 State-of-the-art therapeutics: Hodgkin's lymphoma J Clin Oncol 23 6400 6408 1:CAS:528:DC%2BD2MXhtFWntbfJ 10.1200/JCO.2005.05.016 16155026 (Pubitemid 46222240)
4. JO Armitage 2005 Staging non-Hodgkin lymphoma CA Cancer J Clin 55 368 376 10.3322/canjclin.55.6.368 16282281
5. SB Murphy 1980 Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults Semin Oncol 7 332 339 1:STN:280:DyaL3M%2FhsFGgsA%3D%3D 7414342
6. SB Murphy DL Fairclough RE Hutchison, et al. 1989 Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution J Clin Oncol 7 186 193 1:STN:280: DyaL1M7isFShtg%3D%3D 2915234
7. TC Kwee RM Kwee RA Nievelstein 2008 Imaging in staging of malignant lymphoma: a systematic review Blood 111 504 516 1:CAS:528:DC%2BD1cXns1Chug%3D%3D 10.1182/blood-2007-07-101899 17916746
8. Juweid ME, Stroobants S, Hoekstra OS, et al. Imaging Subcommittee of International Harmonization Project in Lymphoma 2007 Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma J Clin Oncol 25 571 578 10.1200/JCO.2006.08.2305 (Pubitemid 350002965)
9. DJ Brenner EJ Hall 2007 Computed tomography-an increasing source of radiation exposure N Engl J Med 357 2277 2284 1:CAS:528:DC%2BD2sXhsVSlurfF 10.1056/NEJMra072149 18046031 (Pubitemid 350190758)
10. DC Hodgson MM Hudson LS Constine 2007 Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity Semin Radiat Oncol 17 230 242 10.1016/j.semradonc.2007.02.009 17591570 (Pubitemid 46970823)
11. TG Gross AM Termuhlen 2007 Pediatric non-Hodgkin's lymphoma Curr Oncol Rep 9 459 465 1:CAS:528:DC%2BD2sXhtlGgsLjE 10.1007/s11912-007-0064-6 17991353 (Pubitemid 350081482)
12. RC Semelka DM Armao J Elias Jr, et al. 2007 Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI J Magn Reson Imaging 25 900 909 10.1002/jmri.20895 17457809 (Pubitemid 46697559)
13. T Takahara Y Imai T Yamashita, et al. 2004 Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display Radiat Med 22 275 282 15468951
14. TC Kwee T Takahara R Ochiai, et al. 2008 Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology Eur Radiol 18 1937 1952 10.1007/s00330-008-0968-z 18446344
15. GP Schmidt A Baur-Melnyk P Herzog, et al. 2005 High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system Invest Radiol 40 743 753 10.1097/01.rli.0000185878.61270.b0 16304476 (Pubitemid 41690430)
16. DD Brennan T Gleeson LE Coate, et al. 2005 A comparison of whole-body MRI and CT for the staging of lymphoma AJR 185 711 716 1:STN:280: DC%2BD2MvltlSmtw%3D%3D 10.2214/AJR.05.5149 16120924
17. CJ Kellenberger SF Miller M Khan, et al. 2004 Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children Eur Radiol 14 1829 1841 10.1007/s00330-004-2432-z 15365752 (Pubitemid 39386632)
18. TC Kwee HM Quarles van Ufford FJ Beek, et al. 2009 Whole-Body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography Invest Radiol 44 683 690 10.1097/RLI.0b013e3181afbb36 19724232
19. R Walker P Kessar R Blanchard, et al. 2000 Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience J Magn Reson Imaging 11 343 350 1:STN:280:DC%2BD3c3ivFGmtg%3D%3D 10.1002/(SICI)1522-2586(200004)11:4<343:: AID-JMRI1>3.0.CO;2-P 10767062 (Pubitemid 30185873)
20. E Kavanagh C Smith S Eustace 2003 Whole-body turbo STIR MR imaging: controversies and avenues for development Eur Radiol 13 2196 2205 10.1007/s00330-003-1890-z 12715201 (Pubitemid 37080757)
21. CJ Kellenberger M Epelman SF Miller, et al. 2004 Fast STIR whole-body MR imaging in children Radiographics 24 1317 1330 10.1148/rg.245045048 15371611
22. EO Stejskal JE Tanner 1965 Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient J Chem Phys 42 288 292 1:CAS:528:DyaF2MXisFOrtQ%3D%3D 10.1063/1.1695690
23. PW Schaefer PE Grant RG Gonzalez 2000 Diffusion-weighted MR imaging of the brain Radiology 217 331 345 1:STN:280:DC%2BD3crhtFertw%3D%3D 11058626
24. RJ Sevick F Kanda J Mintorovitch, et al. 1992 Cytotoxic brain edema: assessment with diffusion-weighted MR imaging Radiology 185 687 690 1:STN:280:DyaK3s%2Fms12ltw%3D%3D 1438745
25. KP Pruessmann M Weiger MB Scheidegger, et al. 1999 SENSE: sensitivity encoding for fast MRI Magn Reson Med 42 952 962 1:STN:280: DC%2BD3c%2FhtFCruw%3D%3D 10.1002/(SICI)1522-2594(199911)42:5<952::AID- MRM16>3.0.CO;2-S 10542355 (Pubitemid 29521486)
26. K Holzapfel S Duetsch C Fauser, et al. 2008 Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes Eur J Radiol 72 381 387 10.1016/j.ejrad.2008.09.034 18995981
27. AD King AT Ahuja DK Yeung, et al. 2007 Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging Radiology 245 806 813 10.1148/radiol.2451061804 17911539 (Pubitemid 350127351)
28. AA Abdel Razek NY Soliman S Elkhamary, et al. 2006 Role of diffusion-weighted MR imaging in cervical lymphadenopathy Eur Radiol 16 1468 1477 10.1007/s00330-005-0133-x 16557366 (Pubitemid 43871818)
29. M Sumi M Van Cauteren T Nakamura 2006 MR microimaging of benign and malignant nodes in the neck AJR 186 749 757 10.2214/AJR.04.1832 16498102 (Pubitemid 46100259)
30. M Sumi N Sakihama T Sumi, et al. 2003 Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer AJNR 24 1627 1634 13679283
31. Kwee TC, Takahara T, Luijten PR et al (2009) ADC measurements of lymph nodes: Inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol Apr 15 [Epub ahead of print]
32. DG Norris 2001 Implications of bulk motion for diffusion-weighted imaging experiments: effects, mechanisms, and solutions J Magn Reson Imaging 13 486 495 1:STN:280:DC%2BD3M7os1erug%3D%3D 10.1002/jmri.1072 11276093 (Pubitemid 32231503)
33. A Sakurada T Takahara TC Kwee, et al. 2009 Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer Eur Radiol 19 1461 1469 10.1007/s00330-008-1291-4 19172278
34. T Uto Y Takehara Y Nakamura, et al. 2009 Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification Radiology 252 247 254 10.1148/radiol.2521081195 19420317
35. S Satoh Y Kitazume S Ohdama, et al. 2008 Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR 191 464 470 10.2214/AJR.07.3133 18647918
36. T Mori H Nomori K Ikeda, et al. 2008 Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography J Thorac Oncol 3 358 364 10.1097/JTO. 0b013e318168d9ed 18379353 (Pubitemid 351489475)
37. T Laor D Jaramillo 2009 MR imaging insights into skeletal maturation: what is normal? Radiology 250 28 38 10.1148/radiol.2501071322 19092089
38. Y Nonomura M Yasumoto R Yoshimura, et al. 2001 Relationship between bone marrow cellularity and apparent diffusion coefficient J Magn Reson Imaging 13 757 760 1:STN:280:DC%2BD3MvitlemsQ%3D%3D 10.1002/jmri.1105 11329198 (Pubitemid 32381854)
39. M Yasumoto Y Nonomura R Yoshimura, et al. 2002 MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging Skeletal Radiol 31 263 269 1:STN:280:DC%2BD383ktlKhsQ%3D%3D 10.1007/s00256-002-0482-3 11981602 (Pubitemid 36075468)
40. TC Kwee RM Kwee LF Verdonck, et al. 2008 Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma Br J Haematol 141 60 68 10.1111/j.1365-2141.2008.07020.x 18324967 (Pubitemid 351350610)
41. D Baumhoer A Tzankov S Dirnhofer, et al. 2008 Patterns of liver infiltration in lymphoproliferative disease Histopathology 53 81 90 1:STN:280:DC%2BD1cvktVCntQ%3D%3D 10.1111/j.1365-2559.2008.03069.x 18540976 (Pubitemid 351863654)
42. N Berkman R Breuer MR Kramer, et al. 1996 Pulmonary involvement in lymphoma Leuk Lymphoma 20 229 237 1:STN:280:DyaK283htVOjsQ%3D%3D 10.3109/10428199609051612 8624461
43. S Naganawa H Kawai H Fukatsu, et al. 2005 Diffusion-weighted imaging of the liver: technical challenges and prospects for the future Magn Reson Med Sci 4 175 186 10.2463/mrms.4.175 16543702
44. T Parikh SJ Drew VS Lee, et al. 2008 Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging Radiology 246 812 822 10.1148/radiol.2463070432 18223123
45. Kwee TC, Takahara T, Ogino T et al (2009) Diffusion-weighted MR imaging (DWI) using TRacking only Navigator Echo (TRON): initial clinical evaluation and comparison to respiratory triggered and free breathing DWI. Presented at the ISMRM 17th Scientific Meeting & Exhibition, Honolulu, Hawai'i, USA, April 18-24, 2009
46. JA Radford RA Cowan M Flanagan, et al. 1988 The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease J Clin Oncol 6 940 946 1:STN:280:DyaL1c3ivFyisw%3D%3D 3373265
47. G Jerusalem Y Beguin MF Fassotte, et al. 1999 Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging Blood 94 429 433 1:CAS:528:DyaK1MXksVemt7s%3D 10397709
48. C Furth IG Steffen H Amthauer, et al. 2009 Early and late therapy response assessment with [18F] fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial J Clin Oncol 27 4385 4391 10.1200/JCO.2008.19.7814 19667276
49. DA Hamstra CJ Galbán CR Meyer, et al. 2008 Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival J Clin Oncol 26 3387 94 10.1200/JCO.2007.15.2363 18541899
50. DA Hamstra A Rehemtulla BD Ross 2007 Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology J Clin Oncol 25 4104 4109 10.1200/JCO.2007.11.9610 17827460 (Pubitemid 47495868)
51. Takahara T, Ogino T, Okuaki T et al (2007) Respiratory gated body diffusion weighted imaging avoiding prolongation of scan time: tracking only navigator echo (TRON) technique. Presented at the Joint Annual Meeting ISMRM-ESMRMB, Berlin, Germany, May 19-25, 2007
52. F Schick 2005 Whole-body MRI at high field: technical limits and clinical potential Eur Radiol 15 946 959 10.1007/s00330-005-2678-0 15856252 (Pubitemid 41166727)
53. P Mürtz C Krautmacher F Träber, et al. 2007 Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla Eur Radiol 17 3031 3037 10.1007/s00330-007-0717-8 17646990 (Pubitemid 350142327)
54. Willinek WA, Gieseke J, Kukuk G (2009) Parallel RF transmission in body MRI for reduced dielectric shading, improved B1 homogeneity and accelerated imaging at 3.0T: Initial clinical experience in 40 patients using MultiTransmit. Presented at the ISMRM 17th Scientific Meeting & Exhibition, Honolulu, Hawai'i, USA, April 18-24, 2009
55. J Deng FH Miller R Salem, et al. 2006 Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen Invest Radiol 41 769 775 10.1097/01.rli.0000236808.84746.95 16971801 (Pubitemid 44401304)
56. EM Delfaut J Beltran G Johnson, et al. 1999 Fat suppression in MR imaging: techniques and pitfalls Radiographics 19 373 382 1:STN:280: DyaK1M3htVKruw%3D%3D 10194785
57. Z Nagy N Weiskopf 2008 Efficient fat suppression by slice-selection gradient reversal in twice-refocused diffusion encoding Magn Reson Med 60 1256 1260 10.1002/mrm.21746 18956422
58. Takahara T, Zwanenburg J, Visser F et al (2009) Fat suppression with Slice-Selection Gradient Reversal (SSGR) revisited. Presented at the ISMRM 17th Scientific Meeting & Exhibition, Honolulu, Hawai'i, USA, April 18-24, 2009
59. R Weissleder G Elizondo J Wittenberg, et al. 1990 Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging Radiology 175 489 493 1:CAS:528:DyaK3cXkvFCjt7o%3D 2326474 (Pubitemid 20135290)
60. R Weissleder G Elizondo J Wittenberg, et al. 1990 Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging Radiology 175 494 498 1:CAS:528:DyaK3cXkvFCjt7s%3D 2326475 (Pubitemid 20135291)
61. O Will S Purkayastha C Chan, et al. 2006 Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis Lancet Oncol 7 52 60 10.1016/S1470-2045(05)70537-4 16389184 (Pubitemid 43025393)
62. HC Thoeny M Triantafyllou FD Birkhaeuser, et al. 2009 Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients Eur Urol 55 761 769 10.1016/j.eururo.2008.12.034 19144456
63. E Senéterre R Weissleder D Jaramillo, et al. 1991 Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging Radiology 179 529 533 2014305
64. GK Von Schulthess HP Schlemmer 2009 A look ahead: PET/MR versus PET/CT Eur J Nucl Med Mol Imaging 36 Suppl 1 S3 9 10.1007/s00259-008-0940-9
65. PA De Jong HM van Ufford HJ Baarslag, et al. 2009 CT and 18F-FDG-PET for noninvasive detection of splenic involvement in patients with malignant lymphoma AJR 192 745 753 10.2214/AJR.08.1160 19234273
66. EE Pakos AD Fotopoulos JP Ioannidis 2005 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis J Nucl Med 46 958 963 15937306
67. JM Zijlstra G Lindauer-vander Werf OS Hoekstra, et al. 2006 18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review Haematologica 91 522 529 16585017
68. T Terasawa T Nihashi T Hotta, et al. 2008 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review J Nucl Med 49 13 21 10.2967/jnumed.107.039867 18077527
69. GJ Cook I Fogelman MN Maisey 1996 Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation Semin Nucl Med 26 308 314 1:STN:280:DyaK2s%2FntlKisg%3D%3D 10.1016/S0001-2998(96)80006-7 8916319